What are the most common questions about stopping semaglutide
Anyone who experiences a suspected side effect from any medicine including those received within a clinical trial is encouraged to report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app
Diabetes 56, 16711679 (2007)
GLP-1 agonists can drive significant weight loss, but without adequate dietary protein and resistance training, you will lose vital lean muscle massa serious longevity liability
More broadly, compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing
Which causes more weight loss, Cagrilintide or Retatrutide